Nestle India has received approval for execution of a definitive agreement with Dr. Reddy’s Laboratories (Dr. Reddy’s) to form a joint venture and to bring together the well-known global range of nutritional health solutions as well as vitamins, minerals and health supplements of Nestle Health Science with the nutraceuticals portfolios, strong and established commercial strengths of Dr. Reddy’s in India and other geographies as may be agreed by the Parties. The joint venture is expected to become operational in the second quarter of the financial year 2024-25, subject to customary closing conditions. The Board of Directors of the Company, at its meeting held on April 25, 2024, has approved the same.
The joint venture company would be formed with Dr Reddy’s holding 51% and Nestle India’s holding 49%. The company has a call option to increase shareholding upto 60% after six years at a Fair Market Value. Dr Reddy’s shall continue to hold at least 40% of the shareholding after the Company exercises its call option.
Nestle India is a subsidiary of Nestle S.A. of Switzerland, a vibrant company that provides consumers in India with products of global standards.
Company Name | CMP |
---|---|
Nestle | 2163.85 |
Britannia Inds | 4700.90 |
Varun Beverages | 612.20 |
Marico | 628.25 |
Hatsun Agro Product | 1017.85 |
View more.. |